Aerogen is pleased to confirm the successful completion of its recent ISO 14001 (Environmental Management) and ISO 45001 (Occupational Health & Safety Management) surveillance audit.
Aerogen
Corporate Statement
Who we are
Aerogen is a global company headquartered in Galway, Ireland that designs, manufactures and commercialises market-leading products for the acute care sector. With over 25 years of experience, 300 international patents and associated with over 300 clinical papers and publications, Aerogen technology has been used to treat 30 million patients in 80 countries worldwide.1
Our purpose
To positively impact patient outcomes through superior aerosol drug delivery
Our promise
To keep creating industry leading products that deliver improved patient outcomes
Aerogen
News
Aerogen has been named winner of the 2026 AmCham US–Ireland Business Award for Global Impact, recognising the global reach and patient impact of the Aerogen Solo aerosol drug delivery platform.
Aerogen’s R&D Science Laboratories achieve My Green Lab certification
Aerogen is proud to support Galway Hospice, an organisation that provides compassionate, specialist care to patients and families across our community.
A letter of thanks
Continuing our SVP Partnership into 2026
The 12th Zenith Award, a prestigious accolade in the respiratory care profession, signifies over a decade of unwavering commitment to excellence and innovation.
Aerogen Wins Two Major Awards at the Galway Chamber Business Awards
Synairgen and Aerogen Announce Strategic Partnership to Advance Inhaled Therapy for Severe Respiratory Infections
Aerogen expands presence in Japan to advance respiratory care and provide enhanced access to world leading aerosol drug delivery
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company's commitment to advancing respiratory care in India.
Aerogen would like to acknowledge the monumental achievement of the entire team in attaining the globally recognized ISO 14001/45001 certifications.
Aerogen, Irelands largest indigenous Medtech company and a World Leader in hospital-based Aerosol Drug Delivery today celebrates the production of its 20th million Aerogen Solo.
Aerogen announce new distributor partnership for Mexico with Grupo Moravi
Aerogen awarded respiratory therapy: Medication delivery and bronchial hygiene agreement with Premier, Inc.
Aerogen launches new product - Aerojest
Members will now have direct access to Aerogen’s award-winning aerosol drug delivery technology
We are delighted to introduce the world’s first self-delivering medical device.
Druid has announced an exciting new Community and Education programme aimed at deepening engagement with professional theatre within education and local community settings.
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership ...
Today is World Prematurity Day , a day to raise awareness of preterm birth.
The Galway Chamber is an organisation operating under the stewardship of a voluntary Council of 25 members, supported by six committees...
Aerogen has been at the forefront of medical response to the pandemic with our products being used with over 3 million hospitalized and critically ill patients since March 2020.
Galway Women’s FC is delighted to announce a new educational partnership with Galway based med-tech company Aerogen.
Company’s aerosol drug delivery technology used in Phase 1 clinical trial to deliver inhaled type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults without COVID-19 from China.
The National Patient Safety Agency recently issued an alert (NatPSA/2021/003/NHSPS) necessitating organisations to "purchase sufficient powered nebuliser devices for use across the organisation...
UNICEF and Aerogen have announced a two-year partnership in support of UNICEF’s work in the areas of global vaccine equity and the health of newborns.
Aerogen have been shortlisted for two awards in the 46th Business & Finance Awards, in association with KPMG Ireland.
Aerogen, Ireland’s largest indigenous medtech company, has announced the establishment of a new manufacturing operation in Shannon ...
The Irish Medtech Association, the Ibec group that represents the medtech sector, Enterprise Ireland and IDA Ireland have announced that...
A new collaboration between researchers at CÚRAM, the SFI Research Centre based at NUI Galway and Industry partner Aerogen, a world leader ...
EI funded project aims to improve the efficacy of pulmonary drug delivery systems in ICUs
Aerogen has signed an agreement with Synairgen plc, a Southampton, UK-based biotechnology company, to provide the market-leading Aerogen® Solo/Ultra...
NUI Galway, OmniSpirant Limited and Aerogen Limited have been awarded major funding to develop a new aerosol treatment that will transform respiratory medicine...
In a year which will be heralded as one of the toughest that healthcare has had to endure...
Aerogen
Media Contacts
Media Contacts
Before publishing any piece on Aerogen we invite you to reach out to our communications team who can provide further clarity where required. The mailbox marketing@aerogen.com is monitored consistently and is the most efficient way to reach the communications team. Please note, only media enquiries will be responded to. If you have other needs and are looking to contact another group at Aerogen, please visit the contact page
Aerogen
Follow Aerogen
- Aerogen Data on File.
